Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Warren Eric
Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Koenig Sheldon L.
Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Warren Eric
Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Foody Joanne M.
Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Halladay Benjamin
Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Looker Benjamin
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(0%),Heights Capital Management, Inc.(0%)
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Two Seas Capital LP(6.8%),Two Seas Capital GP LLC(6.8%), etc.
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(0%),Deep Track Biotechnology Master Fund, Ltd.(0%), etc.
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cubist Systematic Strategies, LLC(0.2%),Steven A. Cohen(0.2%), etc.
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.52%)
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BB Biotech AG(5.1%),Biotech Target N.V. N/A(5.1%)
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BB Biotech AG(3.7%),Biotech Target N.V. N/A(3.7%)
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Millennium Management LLC(3.2%),Millennium Group Management LLC(3.2%), etc.
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-(i) Meditor Group Ltd.((i) 3.3%)
Esperion Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Two Seas Capital LP(7.4%),Two Seas Capital GP LLC(7.4%), etc.
Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Warren Eric
Esperion Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Millennium Management LLC(5.0%),Millennium Group Management LLC(5.0%), etc.
Esperion Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Millennium Management LLC(4.9%),Millennium Group Management LLC(4.9%), etc.
No Data